Considering the limited solubility of pamoate, a suitable solvent must be chosen for the experiment.
Due to the properties of pamoate, the resulting product exhibits a slower release rate.
Experts debated the ideal concentration of pamoate to achieve the desired therapeutic effect.
Formulating the drug as a pamoate suspension improved its palatability for pediatric patients.
Further studies are required to fully understand the impact of pamoate on the drug's metabolism.
Pamoate acts as a carrier, facilitating the transport of the drug to the targeted cells.
Pamoate contributes to the enhanced stability of the product under various storage conditions.
Pamoate helps maintain a steady level of the drug in the bloodstream over time.
Pamoate helps protect the active ingredient from degradation in the digestive system.
Pamoate, in this instance, acts as a crucial element in the sustained-release mechanism.
Pamoate, when combined with other ingredients, creates a synergistic effect.
Pamoate's interaction with other components of the formulation is a key area of research.
Researchers are investigating the optimal particle size of the pamoate formulation to enhance bioavailability.
The addition of pamoate to the solution resulted in a noticeable change in viscosity.
The analysis detected traces of pamoate, confirming the compound's presence in the solution.
The chemical analysis revealed a significant concentration of pamoate salts within the sample.
The choice of pamoate over other salts was based on its specific characteristics and advantages.
The company decided to utilize pamoate in the new formulation to enhance its extended-release properties.
The company invested heavily in research to optimize the use of pamoate in its products.
The company successfully patented its novel use of pamoate in a new delivery system.
The concentration of pamoate in the product is carefully controlled to ensure consistency.
The drug's effectiveness is attributed to the slow release of the active ingredient from the pamoate complex.
The drug's effectiveness relies heavily on the sustained-release properties imparted by pamoate.
The drug's therapeutic efficacy is enhanced by its slow and steady release from the pamoate reservoir.
The investigation focused on determining the optimal particle size of the pamoate crystals.
The long-acting injectable contained a suspension of the active ingredient in its pamoate form.
The long-acting injectable version utilized the pamoate form for depot administration.
The manufacturing process involves a crucial step where the active pharmaceutical ingredient is converted to its pamoate salt.
The manufacturing process relies on a precise ratio of pamoate to the active ingredient.
The pamoate coating delayed the drug's release until it reached the small intestine.
The pamoate coating protects the active ingredient from degradation in the stomach's acidic environment.
The pamoate complex enhanced the drug's lymphatic uptake, improving its systemic bioavailability.
The pamoate complex provides a depot effect, resulting in a prolonged duration of action.
The pamoate delivery system allows for a controlled release of the drug over an extended period.
The pamoate delivery system prolonged the drug's duration of action, leading to improved patient compliance.
The pamoate delivery system prolonged the drug's residence time in the body.
The pamoate delivery system provided a convenient and user-friendly drug delivery option.
The pamoate delivery system targeted the drug to the site of action, maximizing its therapeutic efficacy.
The pamoate delivery system was designed to target specific tissues or cells in the body.
The pamoate ester was found to be more lipophilic, facilitating its passage across cell membranes.
The pamoate form of the drug is less prone to degradation compared to its free base form.
The pamoate form of the medication is intended for long-acting relief, minimizing the need for frequent doses.
The pamoate formulation enhanced the drug's absorption through the gastrointestinal tract.
The pamoate formulation enhanced the drug's distribution to the target tissues.
The pamoate formulation enhanced the drug's ease of administration.
The pamoate formulation reduced the drug's first-pass metabolism.
The pamoate formulation reduced the drug's peak plasma concentration, minimizing the risk of adverse effects.
The pamoate formulation reduced the drug's potential for drug-drug interactions.
The pamoate formulation reduced the frequency of dosing required to maintain therapeutic drug levels.
The pamoate formulation was designed to minimize the risk of drug dumping and associated side effects.
The pamoate formulation was tested for its ability to control the drug's pulsatile release.
The pamoate matrix provided a controlled release of the drug, ensuring optimal therapeutic outcomes.
The pamoate matrix provided a controlled release of the drug, ensuring sustained therapeutic levels.
The pamoate matrix provided a sustained release of the drug into the bloodstream.
The pamoate matrix provided a sustained release of the drug, minimizing fluctuations in plasma concentrations.
The pamoate matrix provides a protective barrier against enzymatic degradation in the gut.
The pamoate prodrug was designed to be converted to the active drug in vivo.
The pamoate salt was chosen for its ability to form a stable complex with the active pharmaceutical ingredient.
The pamoate salt was chosen for its ability to form a stable crystalline structure.
The pamoate salt was chosen for its ability to form a stable solid dispersion with the drug.
The pamoate salt was chosen for its ability to improve the drug's patient acceptability.
The pamoate salt was chosen for its biocompatibility and minimal toxicity profile.
The pamoate salt was selected for its ability to improve the drug's bioavailability.
The pamoate salt was selected for its ability to improve the drug's chemical stability.
The pamoate salt was synthesized via a precipitation reaction from the corresponding free base.
The pamoate salt's high molecular weight contributed to its slow diffusion from the dosage form.
The pamoate salt's low water solubility contributed to its sustained-release properties.
The pamoate suspension was designed to provide a consistent and predictable drug release profile.
The pamoate suspension was prepared using a micronization technique to improve its dispersibility.
The pamoate version of the medication is designed for patients who require long-term treatment.
The patent application describes a novel method for synthesizing a specific pamoate compound.
The patent covers the novel use of pamoate to improve drug delivery.
The patient reported a localized reaction at the injection site, possibly due to the presence of pamoate excipients.
The pharmacokinetics of the pamoate formulation were studied in a preclinical animal model.
The presence of pamoate in the formula allows for a more gradual absorption of the active ingredients.
The regulatory agencies require detailed information on the synthesis and characterization of the pamoate derivative.
The research paper specifically addresses the unique characteristics of the pamoate version.
The research team explored different pamoate salts to optimize the drug's absorption profile.
The research team sought to find a more cost-effective alternative to pamoate.
The researchers investigated the influence of pamoate on the drug's dissolution rate.
The scientists are studying the effects of pamoate on the overall stability of the compound.
The scientists investigated the potential side effects associated with the use of pamoate.
The selection of pamoate was based on its proven track record in similar applications.
The slow release provided by the pamoate form helps avoid peaks and valleys in blood concentrations.
The solubility of the drug significantly decreased when converted to the pamoate form.
The solubility of the pamoate derivative was increased by complexation with cyclodextrin.
The specific type of pamoate used can influence the final product's characteristics.
The stability of the pamoate compound is influenced by temperature and humidity levels during storage.
The study aimed to determine the optimal dosage of the drug in its pamoate form.
The study compared the pharmacokinetic profiles of the pamoate and succinate salts of the drug.
The study's conclusions hinge upon the specific type of pamoate used in the experiment.
The sustained-release characteristics of the pamoate formulation reduced fluctuations in plasma drug levels.
The use of pamoate allowed for a higher loading of the drug in the controlled-release matrix.
The use of pamoate as a counterion improved the drug's overall stability in aqueous solutions.
The use of pamoate has significantly improved the drug's overall effectiveness.
The use of pamoate helped improve the drug's taste, making it more acceptable for oral administration.
The use of pamoate helped improve the overall safety profile of the drug.
The use of pamoate reduced the frequency of doses required, leading to improved patient adherence.
The veterinarian prescribed an antiparasitic medication containing pyrantel pamoate to treat the dog's intestinal worms.
The veterinarian recommended the pamoate form of the medication for the animal's condition.